Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Claudication

NCT01131013 is registered in ClinicalTrials.gov with Cytokinetics as lead sponsor.

NCT NCT01131013
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01131013 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Three-Way Crossover, Pharmacokinetic and Pharmacodynamic Study of CK-2017357 in Patients With Claudication
Lead sponsor
Cytokinetics
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2010
Completion date
March 31, 2011
Enrollment
61 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

intermittent claudication, peripheral artery disease